Sign Up to like & get
recommendations!
0
Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-7212
Abstract: Objective: To evaluate the efficacy of first-line Pola-R-CHP therapy in patients with high-risk diffuse large B-cell lymphoma (DLBCL) at a single center in China under real-world conditions. Methods: We retrospectively analyzed newly diagnosed CD20-positive DLBCL…
read more here.
Keywords:
pola chp;
line pola;
pola;
first line ... See more keywords